Crown Electrokinetics Corp.

CRKN Basic Materials Specialty Chemicals

Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.00 0.01 −100.00%
Market cap
$5.8M
P/E
0.0×
Fwd P/E
0.3×
Dividend yield
—
F-score
n/a
Altman Z
52.49
Beneish M
n/a
Dividend safety
n/a
Older periods Jun '24 Sep '24 Dec '24 Mar '25
ROE

+8 more TTM periods

(416.46%) (317.74%) (241.21%) (195.09%)
ROA
(197.36%) (204.75%) (145.89%) (142.30%)
ROIC
(232.29%) (186.21%) (163.47%) (134.95%)
Return on Tangible Assets
(431.17%) (390.70%) (155.75%) (108.10%)
Average Days of Receivables
223.97 132.02 99.23 82.75
Free Cash Flow per Share
(1,550.85) (619.33) (0.41) (20.48)
Free Cash Flow
(18.14) (19.32) (24.33) (34.26)
Capital Expenditures
(1.52) (3.21) (6.14) (7.74)
Other line items
Cash ROIC
(138.85%) (145.07%) (66.42%) (58.12%)
Accounts Receivable Turnover
3.24 5.29 7.24 7.62
Accounts Payable Turnover
3.41 4.28 5.89 7.71
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
117.34 119.50 97.21 57.45
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
69.27% 29.80% 17.09% 16.92%
Selling, General and Administrative Expense of Revenue
243.95% 125.46% 101.75% 118.97%
Share Based Compensation of Revenue
51.73% 35.99% 26.65% 32.54%
Interest Coverage
(3.21) (6.17) (24.27) 473.77
Operating CF/Net income
0.60 0.53 0.56 0.71
Depreciation/Fixed assets
2.29 1.00 0.38 0.27
Capex/Depreciation
(0.22) (0.60) (1.92) (3.04)
Revenue per Share
466.75 431.44 0.33 13.03
Operating CF per Share
(1,420.77) (516.38) (0.31) (15.85)
Capex per Share
(130.09) (102.95) (0.10) (4.63)
Capex to Sales
0.28 0.24 0.31 0.36

Fold the line items

Columns are period end dates